These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 31091595)
1. [Circulating tumor cells in pancreatic cancer patients: progression in the detection methods and clinical application]. Zhao XD; Ma YS; Tian XD; Yang YM Zhonghua Wai Ke Za Zhi; 2019 May; 57(5):393-396. PubMed ID: 31091595 [TBL] [Abstract][Full Text] [Related]
2. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice. Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364 [TBL] [Abstract][Full Text] [Related]
3. Circulating tumor cells in pancreatic cancer patients: methods of detection and clinical implications. Tjensvoll K; Nordgård O; Smaaland R Int J Cancer; 2014 Jan; 134(1):1-8. PubMed ID: 23447365 [TBL] [Abstract][Full Text] [Related]
6. Progress and challenges of sequencing and analyzing circulating tumor cells. Zhu Z; Qiu S; Shao K; Hou Y Cell Biol Toxicol; 2018 Oct; 34(5):405-415. PubMed ID: 29168077 [TBL] [Abstract][Full Text] [Related]
7. Circulating Tumor Cells and Implications of the Epithelial-to-Mesenchymal Transition. Lowes LE; Allan AL Adv Clin Chem; 2018; 83():121-181. PubMed ID: 29304900 [TBL] [Abstract][Full Text] [Related]
8. A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer. Barbazán J; Muinelo-Romay L; Vieito M; Candamio S; Díaz-López A; Cano A; Gómez-Tato A; Casares de Cal Mde L; Abal M; López-López R Int J Cancer; 2014 Dec; 135(11):2633-43. PubMed ID: 24752533 [TBL] [Abstract][Full Text] [Related]
9. Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatment. Bredemeier M; Edimiris P; Tewes M; Mach P; Aktas B; Schellbach D; Wagner J; Kimmig R; Kasimir-Bauer S Oncotarget; 2016 Jul; 7(27):41677-41690. PubMed ID: 27223437 [TBL] [Abstract][Full Text] [Related]
10. Opportunities and Challenges for Pancreatic Circulating Tumor Cells. Nagrath S; Jack RM; Sahai V; Simeone DM Gastroenterology; 2016 Sep; 151(3):412-26. PubMed ID: 27339829 [TBL] [Abstract][Full Text] [Related]
11. Monitoring of Circulating Tumor Cells by a Combination of Immunomagnetic Enrichment and RT-PCR in Colorectal Cancer Patients Undergoing Surgery. Vojtechova G; Benesova L; Belsanova B; Minarikova P; Levy M; Lipska L; Suchanek S; Zavoral M; Minarik M Adv Clin Exp Med; 2016; 25(6):1273-1279. PubMed ID: 28028983 [TBL] [Abstract][Full Text] [Related]
12. Expression of Epithelial Mesenchymal Transition and Cancer Stem Cell Markers in Circulating Tumor Cells. Werner S; Stenzl A; Pantel K; Todenhöfer T Adv Exp Med Biol; 2017; 994():205-228. PubMed ID: 28560676 [TBL] [Abstract][Full Text] [Related]
13. Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the Haystack. Bulfoni M; Turetta M; Del Ben F; Di Loreto C; Beltrami AP; Cesselli D Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27783057 [TBL] [Abstract][Full Text] [Related]
15. Detection and Clinical Significance of Circulating Tumor Cells in Colorectal Cancer--20 Years of Progress. Hardingham JE; Grover P; Winter M; Hewett PJ; Price TJ; Thierry B Mol Med; 2015 Oct; 21 Suppl 1(Suppl 1):S25-31. PubMed ID: 26605644 [TBL] [Abstract][Full Text] [Related]
16. Analysis of the hormone receptor status of circulating tumor cell subpopulations based on epithelial-mesenchymal transition: a proof-of-principle study on the heterogeneity of circulating tumor cells. Guan X; Ma F; Liu S; Wu S; Xiao R; Yuan L; Sun X; Yi Z; Yang H; Xu B Oncotarget; 2016 Oct; 7(40):65993-66002. PubMed ID: 27602758 [TBL] [Abstract][Full Text] [Related]
17. Circulating tumor cells (Ctc) and kras mutant circulating free Dna (cfdna) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer. Earl J; Garcia-Nieto S; Martinez-Avila JC; Montans J; Sanjuanbenito A; Rodríguez-Garrote M; Lisa E; Mendía E; Lobo E; Malats N; Carrato A; Guillen-Ponce C BMC Cancer; 2015 Oct; 15():797. PubMed ID: 26498594 [TBL] [Abstract][Full Text] [Related]
18. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer. Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810 [TBL] [Abstract][Full Text] [Related]